{"&cites=2249894853776320385&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","url":"https://ashpublications.org/blood/article-abstract/117/19/5019/20991","authors":["E Campo","E Campo SH Swerdlow","E Campo SH Swerdlow NL Harris…"],"year":2011,"numCitations":1800,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3109529/","citationUrl":"http://scholar.google.com/scholar?cites=1901100216588525479&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:p18tFJMQYhoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1901100216588525479&hl=en&as_sdt=2005&sciodt=0,5","publication":"ashpublications.org","p":1,"exp":1596371253185},{"title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","url":"https://www.researchgate.net/profile/Kenji_Ishitsuka/publication/221812443_Defucosylated_Anti-CCR4_Monoclonal_Antibody_KW-0761_for_Relapsed_Adult_T-Cell_Leukemia-Lymphoma_A_Multicenter_Phase_II_Study/links/0f31752f8d4adb6320000000/Defucosylated-Anti-CCR4-Monoclonal-Antibody-KW-0761-for-Relapsed-Adult-T-Cell-Leukemia-Lymphoma-A-Multicenter-Phase-II-Study.pdf","authors":["T Ishida","T Ishida T Joh","T Ishida T Joh N Uike","T Ishida T Joh N Uike K Yamamoto","T Ishida T Joh N Uike K Yamamoto A Utsunomiya…"],"year":2012,"numCitations":511,"pdf":"https://www.researchgate.net/profile/Kenji_Ishitsuka/publication/221812443_Defucosylated_Anti-CCR4_Monoclonal_Antibody_KW-0761_for_Relapsed_Adult_T-Cell_Leukemia-Lymphoma_A_Multicenter_Phase_II_Study/links/0f31752f8d4adb6320000000/Defucosylated-Anti-CCR4-Monoclonal-Antibody-KW-0761-for-Relapsed-Adult-T-Cell-Leukemia-Lymphoma-A-Multicenter-Phase-II-Study.pdf","citationUrl":"http://scholar.google.com/scholar?cites=12807997211900131448&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:eDiAw5olv7EJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12807997211900131448&hl=en&as_sdt=2005&sciodt=0,5","publication":"researchgate.net"},{"title":"Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3083873/","authors":["OA O'Connor","OA O'Connor B Pro","OA O'Connor B Pro L Pinter"],"year":2011,"numCitations":497,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3083873/","citationUrl":"http://scholar.google.com/scholar?cites=17708491340545853085&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:nQZR9QwzwfUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17708491340545853085&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy","url":"https://www.researchgate.net/profile/Henry_Prince3/publication/221771982_Results_From_a_Pivotal_Open-Label_Phase_II_Study_of_Romidepsin_in_Relapsed_or_Refractory_Peripheral_T-Cell_Lymphoma_After_Prior_Systemic_Therapy/links/5651a8b608aefe619b1821ea/Results-From-a-Pivotal-Open-Label-Phase-II-Study-of-Romidepsin-in-Relapsed-or-Refractory-Peripheral-T-Cell-Lymphoma-After-Prior-Systemic-Therapy.pdf","authors":["B Coiffier","B Coiffier B Pro","B Coiffier B Pro HM Prince","B Coiffier B Pro HM Prince F Foss…"],"year":2012,"numCitations":488,"pdf":"https://www.researchgate.net/profile/Henry_Prince3/publication/221771982_Results_From_a_Pivotal_Open-Label_Phase_II_Study_of_Romidepsin_in_Relapsed_or_Refractory_Peripheral_T-Cell_Lymphoma_After_Prior_Systemic_Therapy/links/5651a8b608aefe619b1821ea/Results-From-a-Pivotal-Open-Label-Phase-II-Study-of-Romidepsin-in-Relapsed-or-Refractory-Peripheral-T-Cell-Lymphoma-After-Prior-Systemic-Therapy.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2507302346412368973&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:TaRpJjO6yyIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2507302346412368973&hl=en&as_sdt=2005&sciodt=0,5","publication":"researchgate.net"},{"title":"Non-hodgkin lymphoma","url":"https://www.sciencedirect.com/science/article/pii/S0140673612606059","authors":["KR Shankland","KR Shankland JO Armitage","KR Shankland JO Armitage BW Hancock"],"year":2012,"numCitations":486,"pdf":"https://redbook.streamliners.co.nz/restricted_access/Shankland%20NHL%20lancet%20review.pdf","citationUrl":"http://scholar.google.com/scholar?cites=8146580015576870197&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:NW3Bmlx3DnEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8146580015576870197&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","url":"https://www.researchgate.net/profile/Outi_Kuittinen/publication/230592872_Up-Front_Autologous_Stem-Cell_Transplantation_in_Peripheral_T-Cell_Lymphoma_NLG-T-01/links/56e111cb08aec4b3333d1ea6/Up-Front-Autologous-Stem-Cell-Transplantation-in-Peripheral-T-Cell-Lymphoma-NLG-T-01.pdf","authors":["F d'Amore","F d'Amore T Relander","F d'Amore T Relander GF Lauritzsen…"],"year":2012,"numCitations":409,"pdf":"https://www.researchgate.net/profile/Outi_Kuittinen/publication/230592872_Up-Front_Autologous_Stem-Cell_Transplantation_in_Peripheral_T-Cell_Lymphoma_NLG-T-01/links/56e111cb08aec4b3333d1ea6/Up-Front-Autologous-Stem-Cell-Transplantation-in-Peripheral-T-Cell-Lymphoma-NLG-T-01.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18017086829675230971&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:-zYpUgONCfoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18017086829675230971&hl=en&as_sdt=2005&sciodt=0,5","publication":"researchgate.net"},{"title":"Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma","url":"https://ashpublications.org/blood/article-abstract/117/22/5827/21443","authors":["RL Piekarz","RL Piekarz R Frye","RL Piekarz R Frye HM Prince","RL Piekarz R Frye HM Prince MH Kirschbaum","RL Piekarz R Frye HM Prince MH Kirschbaum J Zain…"],"year":2011,"numCitations":409,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112033/","citationUrl":"http://scholar.google.com/scholar?cites=2686038698096449092&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:RNb99Pa5RiUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2686038698096449092&hl=en&as_sdt=2005&sciodt=0,5","publication":"ashpublications.org"},{"title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","url":"https://ascopubs.org/doi/abs/10.1200/jco.2009.25.3575","authors":["K Yamamoto","K Yamamoto A Utsunomiya","K Yamamoto A Utsunomiya K Tobinai…"],"year":2010,"numCitations":341,"pdf":"/scholar?output=instlink&q=info:IkHgtyLckasJ:scholar.google.com/&hl=en&as_sdt=2005&sciodt=0,5&scillfp=9304890670295286145&oi=lle","citationUrl":"http://scholar.google.com/scholar?cites=12362904493780648226&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:IkHgtyLckasJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12362904493780648226&hl=en&as_sdt=2005&sciodt=0,5","publication":"ascopubs.org"},{"title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","url":"https://ashpublications.org/blood/article-abstract/117/12/3402/20442","authors":["DD Weisenburger","DD Weisenburger KJ Savage","DD Weisenburger KJ Savage NL Harris…"],"year":2011,"numCitations":327,"pdf":"https://iris.unimore.it/bitstream/11380/662446/1/3402.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13300338141744254497&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Ic4-WxJLlLgJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13300338141744254497&hl=en&as_sdt=2005&sciodt=0,5","publication":"ashpublications.org"},{"title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","url":"https://ashpublications.org/blood/article-abstract/115/5/1026/26647","authors":["J Iqbal","J Iqbal DD Weisenburger","J Iqbal DD Weisenburger TC Greiner","J Iqbal DD Weisenburger TC Greiner JM Vose…"],"year":2010,"numCitations":313,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817630/","citationUrl":"http://scholar.google.com/scholar?cites=14310051548346658633&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:SS-7uBCEl8YJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14310051548346658633&hl=en&as_sdt=2005&sciodt=0,5","publication":"ashpublications.org"}]}